Despite these findings, studies on ADAM12 in haematological disease are scarce when compared with non-haematological diseases, which makes the role of ADAM12 in CLL patients remains ambiguous. This evidence concerns the gene ADAM12 and B-cell chronic lymphocytic leukemia.